BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
Launched by TECHNICAL UNIVERSITY OF MADRID · Feb 26, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The BEAMER project is a clinical trial aimed at improving how patients stick to their treatment plans for various health conditions, including heart disease, diabetes, immune disorders, brain disorders, cancer, and rare diseases. Many people struggle to follow their prescribed treatments, leading to more doctor visits and even serious health issues. This trial focuses on understanding patients' needs and preferences to create personalized support solutions that help them adhere to their treatments better. The project has developed a tool called B-COMPASS, which uses a questionnaire to predict how well patients might follow their treatment and to identify what kind of help they might need.
To participate in this study, individuals must have a diagnosis related to the conditions mentioned and must be willing to engage in all study activities. They will need to provide written consent to join. The trial is not yet recruiting participants, but when it does, those involved can expect to share their experiences and receive tailored support aimed at improving their treatment adherence. This research aims not only to enhance individual health outcomes but also to make healthcare more effective and cost-efficient.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having the diagnosis of the pilot sites target groups described above as per clinical assessment or validated diagnosis criteria
- • Having the age of the pilot sites target groups described above
- • Having accepted to participate in the study and provided written informed consent
- • Having the availability to participate on all study activities
- Exclusion Criteria:
- • Individuals that do not fulfil ALL the inclusion criteria will be excluded to participate.
About Technical University Of Madrid
The Technical University of Madrid (Universidad Politécnica de Madrid, UPM) is a prestigious academic institution renowned for its commitment to advancing research and innovation in engineering, technology, and the applied sciences. With a strong emphasis on interdisciplinary collaboration, UPM actively engages in cutting-edge clinical trials aimed at improving healthcare solutions and enhancing patient outcomes. The university's robust infrastructure, coupled with a team of experienced researchers and clinicians, enables the development and evaluation of novel therapies and medical technologies, positioning UPM as a leader in the translation of scientific discoveries into tangible clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Porto, , Portugal
Patients applied
Trial Officials
Giuseppe Fico, Professor
Principal Investigator
Universidad Politecnica de Madrid
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported